Agreed Text,
Perhaps I should have just said "Traders leaving the building?" (dropped the word Day).
IMO we agree RHT's pendulum has shifted to an investor stock as opposed to a traders stock.
Slow and steady, and it's growth in SP will be based on it's ability to hit revenue forecasts and growth.
On the flip side of the "occasional off report or technical issue", they are bringing other medical diagnosis products to market and continuing to research for other product offerings. In time these new offerings will grow revenue opportunities.
Looking forward to the results of the next 2 QTRs and beyond!.
GLTAH
Chart, page-2905
-
- There are more pages in this discussion • 85 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
